(Q52622926)

English

Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials: A PRISMA-compliant article.

scientific article published in March 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 June 2018

http://europepmc.org/abstract/PMC/5895369

4 references

13 March 2019

24 March 2019

2 August 2019

29 May 2020

0 references

Efficacy of febuxostat in hyperuricemic patients with mild-to-moderate chronic kidney disease: a meta-analysis of randomized clinical trials: A PRISMA-compliant article. (English)

1 reference

Europe PubMed Central

13 June 2018

http://europepmc.org/abstract/PMC/5895369

4 references

13 March 2019

24 March 2019

2 August 2019

29 May 2020

chronic renal insufficiency

4 references

13 March 2019

24 March 2019

2 August 2019

29 May 2020

1 reference

2 August 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Xiang Xia Zeng

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yunliang Tang

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kaixiang Hu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xi Zhou

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jiao Wang

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Lingyan Zhu

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jianying Liu

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

0 references

publication date

1 March 2018

5 references

Europe PubMed Central

13 June 2018

http://europepmc.org/abstract/PMC/5895369

13 March 2019

24 March 2019

2 August 2019

29 May 2020

5 references

13 March 2019

24 March 2019

2 August 2019

29 May 2020

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

97

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

e0161

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

4 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

2 August 2019

Europe PubMed Central

29 May 2020

on focus list of Wikimedia project

0 references

Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Preservation of renal function during gout treatment with febuxostat: a quantitative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Uric acid and long-term outcomes in CKD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Elevated uric acid increases the risk for kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Uric acid and incident kidney disease in the community

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Uric acid, the metabolic syndrome, and renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Hyperuricemia induces endothelial dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Renal involvement follows cardiac enlargement in essential hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

14 June 2018

Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

16 June 2018

The role of hyperuricemia and gout in kidney and cardiovascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

16 June 2018

Prevalence of contraindications and prescription of pharmacologic therapies for gout.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

13 August 2018

Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

13 August 2018

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

13 August 2018

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

13 August 2018

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

13 August 2018

Serum Uric Acid Exhibits Inverse Relationship with Estimated Glomerular Filtration Rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

30 November 2018

Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5895369

30 November 2018

Uric acid and cardiovascular risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/29595642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A repeated oral administration study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with impaired renal function in Japan: pharmacokinetic and pharmacodynamic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29595642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/29595642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, efficacy and renal effect of febuxostat in patients with moderate-to-severe kidney dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/29595642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/MD.0000000000010161

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

release_b4d77oe2rbfsvepke5fsadfie4

1 reference

https://api.fatcat.wiki/v0/release/b4d77oe2rbfsvepke5fsadfie4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29595642%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52622926&oldid=1836757766"